1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394–424. http://doi.org/10.3322/caac.21492.
2.Organization World Health. Cervical cancer. World Health Organization: Geneva, 2018. http://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/. Accessed 25 April 2020.
3.Organization World Health. Strategic framework for the comprehensive control of cancer cervix in South-East Asia Region, 2005. http://doi.org/10.1586/eri.10.139.
4.Sriplung H, Singkham P, Iamsirithaworn S. Jiraphongsa C, Bilheem S. Success of a cervical cancer screening program: trends in incidence in Songkhla, Southern Thailand, 1989–2010, and prediction of future incidences to 2030. Asian Pac J Cancer Prev. 2014; 15: 10003–8. http://doi.org/10.7314/apjcp.2014.15.22.10003.
5.Working Party. National Cervical screening program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. Cancer Council: Sydney, 2016. https://wiki.cancer.org. au/australia/Guidelines:Cervical_cancer/Screening. Accessed 4 July 2018.
6.Cohen PA, Jhingran A, Oaknin A. Denny L. Cervical cancer. Lancet. 2019; 12: 169-82. http://doi.org/10.1016/S0140-6736(18)32470-X.
7.Allemani C. Weir HK, Carreira H, Harewood R, Spika D, Wang X, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385: 977-1010. http://doi.org/10.1016/S0140-6736(14)62038-9.
8.Ifediora CO. Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools. BMC Public Health. 2019; 19:503. http://doi.org/10.1186/s12889-019-6890-2.
9.Hansen RP, Olesen F, Sørensen HT, Sokolowski I, Sondergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: A Danish Cohort Study. BMC Health Serv Res. 2008; 8: 49. http://doi.org/10.1186/1472-6963-8-49.
10.Ramey SJ, Asher D, Kwon D, Ahmed AA, Wolfson AH, Yechieli R, Portelance L. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact. Gynecol Oncol. 2018; 149: 53-62. http://doi.org/10.1016/j.ygyno.2017.12.010.
11.Mukama T, Ndejjo R, Musabyimana A, Halage AA, Musoke D. Women’s knowledge and attitudes towards cervical cancer prevention: a cross sectional study in Eastern Uganda. BMC Womens Health. 2017; 17:9. http://doi.org/10.1186/s12905-017-0365-3.
12.Simon AE, Wardle J, Grimmett C, Power E, Corker E, Menon U, Matheson L, Waller J. Ovarian and cervical cancer awareness: development of two validated measurement tools. J Fam Plann Reprod Health Carea. 2012; 38: 167-74. http://doi.org/10.1136/jfprhc-2011-100118.
13.Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000; 25: 3186‐91. http://doi.org/10.1097/00007632-200012150-00014.
14.Blair J, Ackermann A, Piccinino L, Levenstein R. Using Behavior Coding to Validate Cognitive Interview Findings. Proceedings of the Survey Research Methods Section, ASA, Anaheim, CA. 2007.
15.Tafforeau J, Cobo ML, Tolonen H, Scheidt-Nave C, Tinto A. Guidelines for the Development and Criteria for the Adoption of Health Survey Instruments. http://ec.europa.eu/health/ph_information/dissemination/reporting/healthsurveys_en.pdf. Accessed 23 November 2020.
16.Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007; 30: 459–67. http://doi.org/10.1002/nur.20199.
17.Hagell P, Alvariza A, Westergren A, Årestedt K. Assessment of burden among family caregivers of people with Parkinson's disease using the Zarit Burden Interview. J Pain Symptom Manage. 2017; 53: 272–8. http://doi.org/10.1016/j.jpainsymman.2016.09.007.
18.Terwee CB, Bot SDM, de Boer MR, van de Windt DAWM, Knol DL, Dekker J, Bouter LM, de Vet HCW. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007; 60: 34-42. http://doi.org/10.1016/j.jclinepi.2006.03.012.
19.Ware JE, Brook RH, Davies-Avery A. Conceptualization and Measurement of Health for Adults in the Health Insurance Study. Vol. I: Model of Health and Methodology. Santa Monica, CA: Rand Corporation, 1980.
20.Cohen RJ, Swerdlik ME. Psychological Testing and Assessment: An Introduction to Tests and Measurement. 6th ed. New York: McGraw-Hill, 2005.
21.McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012; 22: 276‐82. http://doi.org/10.11613/BM.2012.031.
22.DeVellis RF. Scale Development: Theory and Applications. Sage Publications Inc. Thousand Oaks, California, 2003.
23.Al-Khasawneh EM, Leocadio M, Seshan V, Siddiqui ST, Khan AN, Al-Manaseer MM. Transcultural adaptation of the Breast Cancer Awareness Measure. Int Nurs Rev. 2016; 63: 445-54. http://doi.org/10.1111/inr.12265.
24.Yeung MPS, Chan EYY, Wong SYS, Yip BHK, Cheung PS. Hong Kong female's breast cancer awareness measure: Cross-sectional survey. World J Clin Onco. 2019; 10: 98-109. http://doi.org/10.5306/wjco.v10.i2.98.
25.Wu ML. Questionnaire Statistical Analysis and Practice. Chongqing, China: Chongqing Publication, 2010.
26.Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health. 2005; 27: 281–91. http://doi.org/10.1093/pubmed/fdi031.